Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Route De La Corniche 6-8, Serine Building 1066,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.newbiologix.com/
- Keywords
- gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, human cell lines.
- HQ
- Epalinges, Switzerland
Newbiologix Questions
Newbiologix's website is https://www.newbiologix.com/
Newbiologix's LinkedIn profile is https://ch.linkedin.com/company/newbiologix
Newbiologix has
23 employees.
View email and phone details for 23
employees at Newbiologix.
Newbiologix's industry is
Biotechnology Research
Newbiologix's top competitors are
Alloy Therapeutics, Inc.,
Limula,
Haya Therapeutics,
Biopôle Lausanne,
Lineage Cell Therapeutics,
Araris Biotech Ag,
Selexis Sa,
Muvon Therapeutics Ag,
Cutiss Ag,
Immunis, Inc..
Newbiologix's categories are Biotechnology Research
Newbiologix's founding year is 2023
